KRAS and ovarian carcinoma: Our study analyzed the mutational profiles of tumor tissues and cfDNA and this revealed pathogenic variants in the eight TP53, PIK3CA, PTEN, APC, NRAS, KRAS, GNAS, and MET genes in patients with ovarian carcinoma.